Chronic middle ear disease represents a substantial global health challenge, affecting nearly 300 million people worldwide and creating complex management decisions for audiologists and surgeons alike. Chronic suppurative otitis media, […]
The Cochlear™ + ReSound™ bimodal partnership continues to evolve, and we’re excited to share updated recommendations that deliver more sophisticated technology to your patients—at no additional cost. What’s Changed? We’re […]
The Cochlear™ Nucleus® Nexa® System stands alone as the world’s first and only smart cochlear implant system1,* because it uniquely integrates true intelligence into the architecture itself. The Cochlear Nucleus […]
What you’ll learn: Estimated reading time is 15 minutes. In this Q&A, Dr. René Gifford, Chief of Research and Audiology at Hearts for Hearing, offers an early look at the […]
The cochlear implant journey is often complex, requiring patients and families to navigate multiple appointments, logistical challenges, and unfamiliar technology. At the University of Miami, that journey has been reimagined. […]
Understanding speech in noisy environments remains a persistent challenge for cochlear implant (CI) recipients. The Cochlear™ Nucleus® 8 and Kanso® 3 Sound Processors introduce advanced technology designed to automatically optimize […]
For decades, cochlear implants have delivered life-changing outcomes for people with severe to profound hearing loss. Yet, traditional implants have one inherent limitation: they are hardwired. Once implanted, their capabilities […]
In this exclusive interview, we sit down with Dr. Sheryl Lewin, a renowned craniofacial plastic surgeon specializing in pediatric microtia and atresia, to discuss her experience with the Cochlear™ Osia® […]
When it comes to cochlear implant outcomes, not all electrode arrays are created equal. While patient-related factors often lie beyond our control, the design of the electrode array and surgical […]
Co-authored by Kristen Caron, AuD With recent expansions in cochlear implant (CI) candidacy—including Medicare’s updated criteria and the FDA’s approval for single-sided deafness and asymmetric hearing loss—the number of adults […]
End of content
No more pages to load
